EX-23.1 7 exhibit231-10xk.htm EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP Document
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-262568 on Form S-8 of our report dated March 28, 2022, relating to the financial statements of Pear Therapeutics Inc., appearing in this Annual Report on Form 10-K for the year ended December 31, 2021.

/s/ Deloitte & Touche LLP


Boston, Massachusetts
March 28, 2022